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Viruses, cytokines and Kaposi's sarcoma
HIV infection strongly predisposes people to Kaposi's sarcoma, a complex
proliferative lesion driven by autocrine and paracrine cytokine expression;
new evidence implicates a second virus in the etiology of the disease.
Kaposi's sarcoma (KS) is one of the great enigmas of
human oncology. Originally described over 100 years ago
as a rare neoplasm of elderly Mediterranean men, the dis-
ease was subsequently found to be much more common
in Africa. With the widespread use of organ transplanta-
tion, KS has been identified more recently in developed
countries among immunosuppressed transplant recipients.
And now, with the global pandemic of infection with
human immunodeficiency virus (HIV), KS has surfaced
as a major complication of acquired immunodeficiency
syndrome (AIDS): over 20 % of homosexual men with
AIDS present with, or develop, KS [1].
Classical KS takes the form of a violaceous plaque-like or
nodular lesion that is usually found on the skin of the
lower extremities. Clinically, it displays an indolent course,
with progression so slow that many affected individuals
die of other, unrelated causes. The AIDS-associated form,
which is very similar histologically to the classical form
(see below), is more likely to be progressive, usually in-
volving multiple cutaneous sites and not infrequently
affecting lymph nodes, lungs and intestines. In this form,
KS may cause significant morbidity and even mortality.
Histologically, KS is a complicated lesion with many
features that are atypical for a classical malignancy. Unlike
most cancers, which derive from the clonal outgrowth
of a single cell type, typical KS biopsies show multiple
cell types: proliferating spindle-shaped cells thought to
be of endothelial origin, slit-like neovascular structures,
fibroblasts, infiltrating inflammatory cells and extrava-
sated red cells [2]. In its earliest stages, the lesion resembles
granulation tissue. As the lesion progresses, the spindle
cell component tends to become more prominent, ulti-
mately making up the bulk of those lesions that go on to
mass formation.
The gross behavior of KS lesions is also quite distinctive.
In AIDS-associated KS, lesions can arise in multiple lo-
cales (on skin or on mucous membranes of the gastroin-
testinal and respiratory tracts) in a pattern that often seems
more consistent with multiple independent occurrences
than with metastasis from a primary site. In transplant-
associated KS, reduction or cessation of immunosuppres-
sive therapy usually leads to arrest of the growth of the
lesion and, in some patients, to its complete involution.
Additionally, no consistent cytogenetic abnormalities have
been identified in KS samples [2]. Given these complexi-
ties, there is great uncertainty about the degree to which
the spindle cells (or, for that matter, any of the cell types
in the lesion) are transformed. Indeed, it is not clear that
these are the appropriate terms in which to phrase ques-
tions about KS, as it so little resembles traditional cancers.
KS as a disease of growth factors
Our understanding of the pathogenesis of KS has been
immensely advanced by pioneering studies of Gallo,
Ensoli and their co-workers [3], who have developed
procedures for the cultivation and analysis of the spindle-
cell component of AIDS-related KS. Initially, this was
achieved by growing explants of KS lesions in condi-
tioned medium of HTLV-infected cells [3]; subsequent
work has shown that such growth can also be supported
by conditioned medium from mononuclear cells acti-
vated with phytohemagglutinin in the absence of retro-
viral infection [4]. Independently, Roth et al. [5] have
derived cell lines from KS without conditioned medium;
these lines also express certain endothelial markers and
are strongly dependent upon growth factors (in this case,
primarily platelet-derived growth factor, PDGF). Auto-
crine and paracrine mechanisms also appear important in
sustaining proliferation in these cultures, as cell growth
is impaired by depletion of several factors produced by
the AIDS-KS cells themselves (for example, basic fibro-
blast growth factor (bFGF), interleukin (IL-) 1, IL-6 or
PDGF; see below) [5-7].
The relevance of these cell lines to the disease is strongly
supported by their behavior upon subcutaneous inocula-
tion into nude mice [8]. The cells display only limited
ability to grow in such mice and soon involute. But dur-
ing their period of viability, they induce in the surround-
ing tissue a lesion with significant resemblance to early
KS, including slit-like neovascular spaces and infiltrating
mononuclear inflammatory cells. Importantly, most of
this surrounding reaction is of murine rather than human
origin. This suggests that the transferred cells release pro-
inflammatory and angiogenic factors that are responsible
for much of the described histopathology of KS. The
picture thus emerges of KS as a disease driven largely by
cytokines and growth factors (see Fig. 1), a view that
nicely rationalizes both the polyclonality of the lesions
and the absence (in the early stages, at least) of multiple
genetic lesions that fix a fully transformed state in any one
cell type. As cytokine-driven proliferation continues, how-
ever, it is speculated that mutations that further deregulate
spindle-cell growth may arise, accounting for the invasive
character of some advanced KS tumors. Indeed, one KS
cell line derived from a non-AIDS specimen grows well
in soft agar and forms tumors in nude mice [9,10].
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Fig. 1. A model for KS pathogenesis. The spindle cells that are presumed to be the prime movers of KS histopathology are derived from
precursors of putative endothelial origin under the influence of cytokines provided by activated mononuclear cells and/or HIV-infected
T cells and macrophages. The spindle cells themselves elaborate factors that both promote spindle-cell growth in an autocrine or
paracrine fashion, and promote angiogenesis, fibroblast proliferation and inflammatory cell infiltration. A partial list of cytokines pro-
posed to be involved in each of these processes is indicated. Some potential pathogenetic role(s) for the KS-associated herpesvirus [161
are depicted. This agent might infect and deregulate spindle cell progenitors directly, or could infect non-endothelial target cells, lead-
ing indirectly to spindle cell growth (for example, via the production of as-yet uncharacterized growth factors). None of these roles has
yet been substantiated experimentally. Abbreviations are those used in the text, except OSM, oncostatin M.
This view has led to an extensive characterization of the
cytokines released by cultured AIDS-KS cells [2,6,7].
Chief among these are bFGF and IL-1; smaller quantities
of acidic FGF, granulocyte-macrophage colony-stimula-
ting factor (GM-CSF), PDGF, transforming growth fac-
tor (TGF-J3) and IL-6 are also made. IL-1, IL-6,
TGF-13 and GM-CSF could contribute to the inflamma-
tory component of the lesion, and PDGF and FGF to its
fibroblastic component. The potent angiogenic effects of
bFGF and its exuberant production by the spindle cells
have drawn major attention to its role in the neoangio-
genesis that is the distinctive signature of KS. Indeed,
subcutaneous injection of bFGF alone into nude mice
can induce neovascular lesions with several of the features
of KS [11]. This effect can be enhanced by co-injection of
fibronectin, in a response mediated by engagement of
fibronectin's RGD (Arg-Gly-Asp) motifs with integrin
receptors on cell surfaces (exactly how this augments
bFGF responses, however, remains to be determined) [11].
How is the growth factor cascade initiated?
Granting that growth factors play a key role in the pro-
gression of KS still leaves open the question of what initi-
ates this cascade of events. HIV infection cannot be its sole
trigger, as classical and endemic African KS typically arise
in uninfected individuals. Nonetheless, HIV infection is a
major KS risk factor: HIV-positive patients are at 20 000-
fold increased risk for KS compared to the general popula-
tion; the relative risk for HIV-negative transplant recipients
is around 300-fold [1]. (The enormity of both numbers is
to be emphasized: heavy cigarette smoking, for instance,
confers a roughly 40-fold increase in lung cancer risk.)
What accounts for this striking association with HIV?
Gallo, Ensoli and colleagues have shown that cultured
cells infected by HIV express increased levels of several
cytokines, including tumor necrosis factor (TNF), IL-1
and IL-6, all of which can trigger proliferation of cultured
AIDS-KS cells [7,12]. Beyond this, these workers have
argued for a role for a specific virally-encoded gene pro-
duct, HIV tat, in KS pathogenesis. This small polypeptide
is known principally for its intranuclear role in the acti-
vation of HIV gene expression via interaction with the
TAR structure on viral RNA. However, small quantities
of tat are released from infected cells [13], by a mech-
anism that remains poorly understood. At high concen-
trations, extracellular tat can enter cells and be delivered
to nuclei, where it can exert its transactivation function.
At much lower concentrations, however, tat can bind to
the surface of AIDS-KS cells and promote both cell
growth [12] and adhesion to solid surfaces [14]; the latter
effect is reminiscent of the action of fibronectin. In fact,
tat contains an RGD sequence, and RGD-containing pep-
tides block this tat-mediated adhesion reaction [14]. In
keeping with these findings, soluble tat protein can syner-
gize with bFGF in promoting angiogenic lesions upon
subcutaneous inoculation in nude mice, in much the
same fashion as fibronectin does [11]. In the simplest inter-
pretation, these experiments provide a potential rationale
for an etiological link between HIV infection and the ini-
tiation of KS. Supporting this view is the observation that
some transgenic mice expressing tat develop proliferative
dermal lesions containing spindle-shaped cells [15].
Yes, but...
Nevertheless, there are compelling reasons to believe that
other factors are at work in the etiology of KS, and that
these other factors may be even more important in the
initiation of lesions. The main arguments for this derive
from epidemiological studies. First, as noted above, sev-
eral forms of KS occur in the absence of HIV infection.
Second, within the AIDS population, KS is not equally
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distributed among all groups of HIV seropositives. Where-
as about 20 % of homosexual men with AIDS develop
KS, the disease occurs in less than 1 % of hemophiliacs
and 3 % of transfusion recipients with AIDS [1]. Chil-
dren with AIDS, most of whom have acquired HIV in-
fection vertically from their mothers (during pregnancy
or birth), may have even lower rates of KS. All of these
groups develop comparable degrees of immunodeficiency,
so it is difficult to argue that these differences reflect vari-
ations in host susceptibility on this basis.
These facts are difficult to reconcile with an etiological
scheme depending primarily upon tat, and are more con-
sistent with the idea that a sexually transmitted agent or
cofactor is required (in addition to some degree of im-
mune dysfunction) for lesions to develop. In support of
this notion, several reports have appeared of HIV-nega-
tive gay men with KS. Also consistent with this idea is
the declining prevalence of KS in gay males with AIDS
since the introduction of safer-sex practices in the past
decade [1]. But attempts to identify such a pathogen by
classical microbiological methods have failed.
Recently, however, a major advance in KS research was
announced by Chang, Moore and their colleagues at
Columbia University [16]. They employed representa-
tional difference analysis (RDA), a subtraction procedure
based on the polymerase chain reaction (PCR) [17], to
identify DNA sequences present in KS tissue but not in
normal skin. Two such PCR products, of 330 and 631
nucleotides, were recovered from a KS sample. The se-
quences of these clones reveal open reading frames with
predicted products that have homology to known pro-
teins of two lymphotropic herpesviruses, herpesvirus
saimiri (a simian virus linked to T-cell lymphomas) and
the human Epstein-Barr virus. Sequences corresponding
to these clones have been identified by PCR i 25 out of
27 cases of HIV-related KS, compared with none of 90
normal and neoplastic tissues from HIV-negative sources.
Interestingly, 3 of 27 HIV-related lymphomas harbored
these sequences, as did 3 of 12 HIV-positive lymph nodes
[16]. Thus, infection with this agent appears to track
closely with KS or the risk for KS.
Although the story of this agent is in its infancy, the
results to date are extremely promising. Formally, it re-
mains possible that the agent in question is simply a
marker of KS risk. For example, it could represent an op-
portunistic pathogen that preferentially infects immuno-
deficient patients at risk for KS, or which selectively
superinfects cells in KS lesions, but this seems unlikely.
Importantly, preliminary studies from several laboratories
identify similar viral sequences in KS specimens from
several different HIV-negative cohorts as well. These re-
sults greatly strengthen the association of the agent with
Kaposi's sarcoma and support the view that all clinical
forms of the disease may be related.
Much remains to be done to better our understanding of
the association of this agent with KS. Development of a
serological test for the virus will be essential for establish-
ing its epidemiology. This could be done either using
recombinant DNA technology or through cultivation
of the agent. If this is indeed the agent predicted by ear-
lier epidemiological work, its distribution in the general
population should be consistent with sexual transmission.
Similarly,.its distribution among the different subgroups
of HIV-infected patients should track more closely with
KS risk than does HIV seropositivity. If these and other
studies support an etiological role for the virus in KS,
then determination of the molecular mechanisms through
which infection triggers the cytokine-mediated events
described above may at last be possible.
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